DCM
BDSI

DG Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

DG Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-323,330
Closed -$1.23M – 31
2020
Q1 		$1.23M Buy
+323,330
New +$1.59M 1.93% 12

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

DG Capital Management's BDSI Position: Q2 2020 in Review

DG Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2020, closing a stake of 323,330 shares — an estimated $1.23M sold.

DG Capital Management first reported a position in BDSI in Q1 2020 and held it in 1 quarter. The position peaked at $1.23M in Q1 2020. 158 funds tracked by Wall St. Rank hold BDSI as of Q2 2020.

  • DG Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2020 after selling out during the quarter.
  • DG Capital Management sold 323,330 BioDelivery Sciences International, Inc. shares in Q2 2020, an estimated $1.23M.
  • DG Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2020 and held it in 1 quarter.
  • DG Capital Management's BioDelivery Sciences International, Inc. position peaked at $1.23M in Q1 2020.
  • 158 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2020.

Based on DG Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.